Teva to donate over $15 billion worth of drugs in opioid settlement: source

(Reuters) – Teva Pharmaceuticals (N:) is in talks to contribute over $15 billion worth of drugs as part of a settlement to resolve lawsuits alleging it helped fuel the U.S. opioid crisis, a source familiar with the matter told Reuters on Wednesday.

The news follows media reports that major drug distributors McKesson Corp (N:), AmerisourceBergen Corp (N:) and Cardinal Health (N:) are discussing with governments to settle thousands of opioid-related lawsuits for $18 billion.

The companies, including Teva, are all defendants in a landmark trial set to begin in federal court in Cleveland, Ohio, on Oct. 21, which will be presided over by U.S. District Judge Dan Polster, who has long pushed for a global settlement of the litigation.

The source also said Johnson & Johnson Inc (N:) had offered to pay $4 billion to settle claims related to the U.S. opioid epidemic.

Teva has offered to give away generic drugs, including those that help fight opioid overdose, to resolve all of its cases in an agreement that would run over 10 years, Bloomberg reported on Tuesday.

Teva did not immediately respond to Reuters’ request for comment.

If the distributors and Teva settle before the start of the trial, the remaining defendants would be Walgreens Boots Alliance Inc (O:) and Henry Schein Inc (O:).

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.